About Biocurity Pharmaceuticals
Biocurity Pharmaceuticals is a private company based in West Palm Beach, Florida. It has reported $521,400 raised in 17 offerings on Form D since April 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 3, 2023 | Jun 21, 2023 | $16,900of $650K target | 5 | $3,380 | EquityRule 506(b) | Form D ↗ |
| Nov 2, 2022 | Nov 30, 2022 | $11,250of $650K target | 2 | $5,625 | EquityRule 506(b) | Form D ↗ |
| Apr 1, 2022 | Apr 13, 2022 | $75,150of $650K target | 1 | $75,150 | EquityRule 506(b) | Form D ↗ |
| Aug 6, 2021 | Sep 1, 2021 | $18,900of $1.0M target | 2 | $9,450 | EquityRule 506(b) | Form D ↗ |
| May 14, 2021 | May 27, 2021 | $25,200of $1.0M target | 2 | $12,600 | EquityRule 506(c) | Form D ↗ |
| Sep 24, 2019 | Oct 2, 2019 | $15,000of $1.5M target | 1 | $15,000 | EquityRule 506(b) | Form D ↗ |
| Apr 24, 2019 | May 6, 2019 | $0of $300K target | 1 | $0 | EquityRule 506(b) | Form D ↗ |
| Feb 6, 2019 | Feb 7, 2019 | $50,000of $2.0M target | 2 | $25,000 | EquityRule 506(b) | Form D ↗ |
| Not yet | Dec 14, 2018 | $0of $2.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Feb 21, 2018 | $0of $400K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Nov 16, 2017 | $0of $800K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Jun 19, 2017 | $0of $320K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Feb 1, 2017 | $0of $960K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Sep 14, 2016 | $0of $1.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Aug 4, 2016 | Jun 30, 2016amended Aug 8, 2016 | $204,000of $680K target | 1 | $204K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 6, 2016 | Apr 15, 2016 | $105,000of $450K target | 4 | $26,250 | EquityRule 506(b) | Form D ↗ |
| Apr 30, 2015 | Apr 16, 2015amended May 29, 2015 | $0of $1.5M target | 3 | $0 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, 17 offerings | $521,400 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Biocurity Pharmaceuticals's Form D filed Jun 21, 2023.
Earlier filings also listed Aslams Merchant (director, last listed Sep 2021) and Aslam Merchant (director, last listed May 2021).